|
2021 Other Outputs In vitro, classical complement activation differs by disease severity and between SARS-CoV-2 antigensLamerton, Rachel E, Marcial-Juarez, Edith, Faustini, Sian E, Perez-Toledo, Marisol, Goodall, Margaret, Jossi, Siân E, Newby, Maddy L, Chapple, Iain, Dietrich, Thomas, Veenith, Tonny, Shields, Adrian M, Harper, Lorraine, Henderson, Ian R, Rayes, Julie, Wraith, David C, Watson, Steve P, Crispin, Max, Drayson, Mark T, Richter, Alex G and Cunningham, Adam F (2021). In vitro, classical complement activation differs by disease severity and between SARS-CoV-2 antigens. doi: 10.1101/2021.11.22.21266681 |
